OM 85 to Prevent Respiratory Infections in Older At Risk Patients

PHASE4RecruitingINTERVENTIONAL
Enrollment

360

Participants

Timeline

Start Date

February 1, 2025

Primary Completion Date

January 31, 2026

Study Completion Date

April 30, 2026

Conditions
Respiratory Tract Infections (RTI)
Interventions
DRUG

Bacterial Lysate

Administration p.o. for 10 days per month for 3 months, two consecutive cycles.

DRUG

Placebo

Matching placebo.

Trial Locations (1)

00128

RECRUITING

Fondazione Policlinico Campus Bio-Medico, Roma

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

OM Pharma SA

INDUSTRY

lead

Campus Bio-Medico University

OTHER

NCT06655272 - OM 85 to Prevent Respiratory Infections in Older At Risk Patients | Biotech Hunter | Biotech Hunter